Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease

被引:87
作者
Christine, Chadwick W. [1 ]
Auinger, Peggy [2 ]
Joslin, Amelia [3 ]
Yelpaala, Yuora [3 ]
Green, Ralph [3 ]
机构
[1] UCSF, Dept Neurol, 400 Parnassus Ave,Box 0348, San Francisco, CA 94143 USA
[2] Univ Rochester, Ctr Human Expt Therapeut, Rochester, NY USA
[3] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA USA
关键词
cyanocobalamin; gait instability; cognitive impairment; hyperhomocysteinemia; MILD COGNITIVE IMPAIRMENT; PLASMA HOMOCYSTEINE; METHYLMALONIC ACID; POSTURAL INSTABILITY; DATATOP COHORT; RATING-SCALE; RISK-FACTOR; DEFICIENCY; PREVALENCE; NEUROPATHY;
D O I
10.1002/mds.27301
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In moderately advanced Parkinson's disease (PD), low serum vitamin B12 levels are common and are associated with neuropathy and cognitive impairment. However, little is known about B12 in early PD. Objective: To determine the prevalence of low vitamin B12 status in early PD and whether it is associated with clinical progression. Methods: We measured vitamin B12 and other B12 status determinants (methylmalonic acid, homocysteine, and holotranscobalamin) in 680 baseline and 456 follow-up serum samples collected from DATATOP participants with early, untreated PD. Borderline low B12 status was defined as serum B12 < 184 pmol/L (250 pg/mL), and elevated homocysteine was defined as > 15 mmol/L. Outcomes included the UPDRS, ambulatory capacity score (sum of UPDRS items 13-15, 29& 30), and MMSE, calculated as annualized rates of change. Results: At baseline, 13% had borderline low B12 levels, 7% had elevated homocysteine, whereas 2% had both. Elevated homocysteine at baseline was associated with worse scores on the baseline MMSE. Analysis of study outcomes showed that compared with the other tertiles, participants in the low B12 tertile (< 234 pmol/L; 317 pg/mL) developed greater morbidity as assessed by greater annualized worsening of the ambulatory capacity score. Elevated homocysteine was associated with greater annualized decline in MMSE (21.96 vs. 0.06; P = 0001). Blood count indices were not associated with B12 or homocysteine status. Conclusions: In this study of early PD, low B12 status was common. Low B12 at baseline predicted greater worsening of mobility whereas elevated homocysteine predicted greater cognitive decline. Given that low B12 and elevated homocysteine can improve with vitamin supplementation, future studies should test whether prevention or early correction of these nutritionally modifiable conditions slows development of disability. (C) 2018 International Parkinson and Movement Disorder Society
引用
收藏
页码:762 / 770
页数:9
相关论文
共 43 条
[1]   Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease [J].
Ascherio, Alberto ;
LeWitt, Peter A. ;
Xu, Kui ;
Eberly, Shirley ;
Watts, Arthur ;
Matson, Wayne R. ;
Marras, Connie ;
Kieburtz, Karl ;
Rudolph, Alice ;
Bogdanov, Mikhail B. ;
Schwid, Steven R. ;
Tennis, Marsha ;
Tanner, Caroline M. ;
Beal, M. Flint ;
Lang, Anthony E. ;
Oakes, David ;
Fahn, Stanley ;
Shoulson, Ira ;
Schwarzschild, Michael A. .
ARCHIVES OF NEUROLOGY, 2009, 66 (12) :1460-1468
[2]   Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease [J].
Bohnen, Nicolaas I. ;
Mueller, Martijn L. T. M. ;
Zarzhevsky, Natalia ;
Koeppe, Robert A. ;
Bogan, Christopher W. ;
Kilbourn, Michael R. ;
Frey, Kirk A. ;
Albin, Roger L. .
BRAIN, 2011, 134 :2358-2365
[3]   The relationship between hyperhomocysteinemia and neurodegeneration [J].
Bonetti, Francesco ;
Brombo, Gloria ;
Zuliani, Giovanni .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (02) :133-145
[4]   Elevated prenatal homocysteine levels as a risk factor for schizophrenia [J].
Brown, Alan S. ;
Bottiglieri, Teodoro ;
Schaefer, Catherine A. ;
Quesenberry, Charles P., Jr. ;
Liu, Liyan ;
Bresnahan, Michaeline ;
Susser, Ezra S. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (01) :31-39
[5]   Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort [J].
Chou, Kelvin L. ;
Elm, Jordan J. ;
Wielinski, Catherine L. ;
Simon, David K. ;
Aminoff, Michael J. ;
Christine, Chadwick W. ;
Liang, Grace S. ;
Hauser, Robert A. ;
Sudarsky, Lewis ;
Umeh, Chizoba C. ;
Voss, Tiffini ;
Juncos, Jorge ;
Fang, John Y. ;
Boyd, James T. ;
Bodis-Wollner, Ivan ;
Mari, Zoltan ;
Morgan, John C. ;
Wills, Anne-Marie ;
Lee, Stephen L. ;
Parashos, Sotirios A. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 :137-143
[6]   Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial [J].
de Jager, Celeste A. ;
Oulhaj, Abderrahim ;
Jacoby, Robin ;
Refsum, Helga ;
Smith, A. David .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (06) :592-600
[7]   Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease [J].
de Lau, L. M. L. ;
Koudstaal, P. J. ;
Witteman, J. C. M. ;
Hofman, A. ;
Breteler, M. M. B. .
NEUROLOGY, 2006, 67 (02) :315-318
[8]   Plasma vitamin B12 status and cerebral white-matter lesions [J].
de Lau, L. M. L. ;
Smith, A. D. ;
Refsum, H. ;
Johnston, C. ;
Breteler, M. M. B. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (02) :149-157
[9]   Survival in Parkinson's disease. Relation with motor and non-motor features [J].
de Lau, Lonneke M. L. ;
Verbaan, Dagmar ;
Marinus, Johan ;
van Hilten, Jacobus J. .
PARKINSONISM & RELATED DISORDERS, 2014, 20 (06) :613-616
[10]   High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease [J].
Evatt, Marian L. ;
DeLong, Mahlon R. ;
Kumari, Meena ;
Auinger, Peggy ;
McDermott, Michael P. ;
Tangpricha, Vin .
ARCHIVES OF NEUROLOGY, 2011, 68 (03) :314-319